The Brachyury vaccine educates the host immune cells to target the Brachyury protein, and there have been clinical trials to test this vaccine against multiple subtypes of breast cancer (NCT02179515, NCT04296942, NCT04134312, NCT03384316). The gene discussed is TBX1; the disease is breast cancer.